Cervical cancer remains a significant global health challenge, particularly affecting women in low-resource settings. Effective screening methods are essential for early detection and prevention. This ...
Truscreen Group Ltd. completed its largest clinical trial to date that showed its cervical cancer screening device surpassed liquid-based cytology (LBC) screening in 15,651 women across 64 hospitals ...
FRANKLIN LAKES, N.J., May 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
A new computerised screening test for cervical cancer detects more abnormalities than the traditional smear test, according to a study published on bmj.com today. It could also lead to fewer women ...
In addition to the information depicted in Table 1, primary-care clinicians need to be aware of the findings of research studies that surround the administration of the cervical cancer vaccines. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results